Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 5/20 | 0.49 |
| ▸ | NPC1 | O15118 | 4/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
| ▸ | CASP7 | P55210 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5183906 | 0.90 | ALDH1A1 (0.54) | ALDH1A1MAPTL3MBTL1LMNARAB9A | |
| SCHEMBL5184506 | 0.87 | ALDH1A1 (0.54) | ALDH1A1MAPTL3MBTL1LMNARAB9A | |
| SCHEMBL5182346 | 0.87 | ALDH1A1 (0.53) | ALDH1A1MAPTL3MBTL1LMNARAB9A | |
| SCHEMBL5184497 | 0.83 | ALDH1A1 (0.67) | ALDH1A1MAPTL3MBTL1LMNARAB9A | |
| SCHEMBL5183796 | 0.82 | ALDH1A1 (0.46) | ALDH1A1MAPTL3MBTL1LMNARAB9A | |
| SCHEMBL6849219 | 0.81 | ALDH1A1 (0.43) | ALDH1A1MAPTL3MBTL1LMNARAB9A | |
| SCHEMBL6849223 | 0.81 | ALDH1A1 (0.43) | ALDH1A1MAPTL3MBTL1LMNARAB9A | |
| SCHEMBL5182655 | 0.81 | ALDH1A1 (0.49) | ALDH1A1MAPTL3MBTL1LMNARAB9A | |
| SCHEMBL5183398 | 0.81 | MAPT (0.55) | ALDH1A1MAPTL3MBTL1LMNACYP1A2 | |
| SCHEMBL5184946 | 0.79 | ALDH1A1 (0.43) | ALDH1A1MAPTL3MBTL1LMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1301492-B1 | NOVEL TETRAZOLE DERIVATIVES | BAYER CROPSCIENCE KK (JP) | 2007-07-04 | — | — | EP | disclosed |
| US-6770599-B2 | Tetrazole derivatives | BAYER CROPSCIENCE KK (JP) | 2004-08-03 | — | — | US | disclosed |
| US-20030224943-A1 | Novel tetrazole derivatives | BAYER CROPSCIENCE K. K. (JP) | 2003-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030224943-A1 | Novel tetrazole derivatives | CBR3, CBR1, ECH1 | ALDH1A1 783/4885MAPT 4632/4885L3MBTL1 490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.